Skip to Content Skip to Footer
一錠除
MSD Animal Health
Primary Menu
  • 一錠除®產品介紹
    • 犬用錠劑
    • 全效貓用滴劑
  • 好主人獎勵計劃
  • 認識焦蟲症
  • 精選影片
  • 常見問題
  • 聯絡我們
  • 獸醫資訊
  • 購買通路
  • Facebook
  • LINE .cls-1{fill:none;stroke:#000;stroke-miterlimit:10;stroke-width:2px;}.cls-2{fill-rule:evenodd;}

安全性

SAFETY OF CONCURRENT TREATMENT OF DOGS WITH FLURALANER (BRAVECTO™) AND MILBEMYCIN OXIME – PRAZIQUANTEL

SAFETY OF CONCURRENT TREATMENT OF DOGS WITH FLURALANER (BRAVECTO™) AND MILBEMYCIN OXIME – PRAZIQUANTEL

Read more about SAFETY OF CONCURRENT TREATMENT OF DOGS WITH FLURALANER (BRAVECTO™) AND MILBEMYCIN OXIME – PRAZIQUANTEL

SAFETY OF THE CONCURRENT TREATMENT OF DOGS WITH (BRAVECTO™) (FLURALANER) AND SCALIBOR™ PROTECTORBAND (DELTAMETHRIN)

SAFETY OF THE CONCURRENT TREATMENT OF DOGS WITH (BRAVECTO™) (FLURALANER) AND SCALIBOR™ PROTECTORBAND (DELTAMETHRIN)

Read more about SAFETY OF THE CONCURRENT TREATMENT OF DOGS WITH (BRAVECTO™) (FLURALANER) AND SCALIBOR™ PROTECTORBAND (DELTAMETHRIN)

SAFETY OF FLURALANER CHEWABLE TABLETS (BRAVECTO™), A NOVEL SYSTEMIC ANTIPARASITIC DRUG, IN DOGS AFTER ORAL ADMINISTRATION

SAFETY OF FLURALANER CHEWABLE TABLETS (BRAVECTO™), A NOVEL SYSTEMIC ANTIPARASITIC DRUG, IN DOGS AFTER ORAL ADMINISTRATION

Read more about SAFETY OF FLURALANER CHEWABLE TABLETS (BRAVECTO™), A NOVEL SYSTEMIC ANTIPARASITIC DRUG, IN DOGS AFTER ORAL ADMINISTRATION

SAFETY OF FLURALANER, A NOVEL SYSTEMIC ANTIPARASITIC DRUG, IN MDR1 (–/–) COLLIES AFTER ORAL ADMINISTRATION

SAFETY OF FLURALANER, A NOVEL SYSTEMIC ANTIPARASITIC DRUG, IN MDR1 (–/–) COLLIES AFTER ORAL ADMINISTRATION

Read more about SAFETY OF FLURALANER, A NOVEL SYSTEMIC ANTIPARASITIC DRUG, IN MDR1 (–/–) COLLIES AFTER ORAL ADMINISTRATION

Facebook LINE .cls-1{fill:none;stroke:#000;stroke-miterlimit:10;stroke-width:2px;}.cls-2{fill-rule:evenodd;}
  • 犬用錠劑
  • 全效貓用滴劑
  • 精選影片
  • 常見問題
  • 聯絡我們
  • 獸醫資訊
  • 購買通路
  • 隱私權保護政策
  • Accessibility Accessibility button
MSD Animal Health

Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.